203 related items for PubMed ID: 16032934
1. Hydrofluoroalkane-134A beclomethasone or chlorofluorocarbon fluticasone: effect on small airways in poorly controlled asthma.
Thongngarm T, Silkoff PE, Kossack WS, Nelson HS.
J Asthma; 2005 May; 42(4):257-63. PubMed ID: 16032934
[Abstract] [Full Text] [Related]
2. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA, Rooklin A, Schoaf L, Scott C, Ellsworth A, House K, Dorinsky P.
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[Abstract] [Full Text] [Related]
3. Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone.
Fowler SJ, Currie GP, Lipworth BJ.
J Allergy Clin Immunol; 2002 Jun; 109(6):929-35. PubMed ID: 12063520
[Abstract] [Full Text] [Related]
4. Efficacy of HFA-beclomethasone dipropionate extra-fine aerosol (800 microg day(-1)) versus HFA-fluticasone propionate (1000 microg day(-1)) in patients with asthma.
Aubier M, Wettenger R, Gans SJ.
Respir Med; 2001 Mar; 95(3):212-20. PubMed ID: 11266239
[Abstract] [Full Text] [Related]
5. Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol.
Fireman P, Prenner BM, Vincken W, Demedts M, Mol SJ, Cohen RM.
Ann Allergy Asthma Immunol; 2001 May; 86(5):557-65. PubMed ID: 11379808
[Abstract] [Full Text] [Related]
6. Hydrofluoroalkane-134a beclomethasone dipropionate, 400 microg, is as effective as chlorofluorocarbon beclomethasone dipropionate, 800 microg, for the treatment of moderate asthma.
Gross G, Thompson PJ, Chervinsky P, Vanden Burgt J.
Chest; 1999 Feb; 115(2):343-51. PubMed ID: 10027430
[Abstract] [Full Text] [Related]
7. Equivalent asthma control after dose reduction with HFA-134a beclomethasone solution aerosol. Comparative Inhaled Steroid Investigation Group (CISIG).
Magnussen H.
Respir Med; 2000 Jun; 94(6):549-55. PubMed ID: 10921758
[Abstract] [Full Text] [Related]
8. Hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily dose.
Davies RJ, Stampone P, O'Connor BJ.
Respir Med; 1998 Jun; 92 Suppl A():23-31. PubMed ID: 9850360
[Abstract] [Full Text] [Related]
9. Effects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjects.
Chrousos GP, Ghaly L, Shedden A, Iezzoni DG, Harris AG.
Chest; 2005 Jul; 128(1):70-7. PubMed ID: 16002918
[Abstract] [Full Text] [Related]
10. Health-related quality of life in moderate asthma: 400 microg hydrofluoroalkane beclomethasone dipropionate vs 800 microg chlorofluorocarbon beclomethasone dipropionate. The Study Group.
Juniper EF, Buist AS.
Chest; 1999 Nov; 116(5):1297-303. PubMed ID: 10559091
[Abstract] [Full Text] [Related]
11. Switching from conventional to extrafine aerosol beclomethasone dipropionate therapy in children: a 6-month, open- label, randomized trial.
Szefler SJ, Warner J, Staab D, Wahn U, Le Bourgeois M, van Essen-Zandvliet EE, Arora S, Pedersen S, Pediatric Study Group.
J Allergy Clin Immunol; 2002 Jul; 110(1):45-50. PubMed ID: 12110818
[Abstract] [Full Text] [Related]
12. Equivalent efficacy and safety of a new HFA-134a formulation of BDP compared with the conventional CFC in adult asthmatics.
Anderson PB, Langley SJ, Mooney P, Jones J, Addlestone R, Rossetti A, Cantini L.
J Investig Allergol Clin Immunol; 2002 Jul; 12(2):107-13. PubMed ID: 12371526
[Abstract] [Full Text] [Related]
13. Effects of HFA- and CFC-beclomethasone dipropionate on the bronchial response to methacholine (MCh) in mild asthma.
Micheletto C, Guerriero M, Tognella S, Dal Negro RW.
Respir Med; 2005 Jul; 99(7):850-5. PubMed ID: 15939246
[Abstract] [Full Text] [Related]
14. A new HFA-134a propellant in the administration of inhaled BDP via the Jet spacer: controlled clinical trial vs the conventional CFC.
Vondra V, Sladek K, Kotasová J, Terl M, Rossetti A, Cantini L.
Respir Med; 2002 Oct; 96(10):784-9. PubMed ID: 12412977
[Abstract] [Full Text] [Related]
15. Clinical efficacy and safety of fluticasone propionate 1 mg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with severe asthma. U.K. study group.
Ayres JG, Millar AB, Sykes AP.
Respir Med; 2000 Jun; 94 Suppl B():S42-50. PubMed ID: 10919685
[Abstract] [Full Text] [Related]
16. Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone : a cross-over study in healthy volunteers.
Leach CL, Davidson PJ, Hasselquist BE, Boudreau RJ.
Chest; 2002 Aug; 122(2):510-6. PubMed ID: 12171824
[Abstract] [Full Text] [Related]
17. [A multicenter, open-label, randomized comparison of suppressive effects on asthmatic inflammation of lower airways and improved effects on health-related QOL between HFA-BDP and fluticasone propionate].
Ohbayashi H, Adachi M, Ichinose M, Ohta K, Kokubu F, Sano Y, Tamura G, Tohda Y, Hirata K, Yasuba H.
Arerugi; 2007 Jun; 56(6):577-86. PubMed ID: 17615501
[Abstract] [Full Text] [Related]
18. Therapeutic equivalence of inhaled beclomethasone dipropionate with CFC and non-CFC (HFA 134a) propellants both delivered via the Easibreathe inhaler for the treatment of paediatric asthma.
Farmer IS, Middle M, Savic J, Perri VL, Herdman MJ.
Respir Med; 2000 Jan; 94(1):57-63. PubMed ID: 10714480
[Abstract] [Full Text] [Related]
19. Airway and systemic effects of hydrofluoroalkane fluticasone and beclomethasone in patients with asthma.
Currie GP, Fowler SJ, Wilson AM, Sims EJ, Orr LC, Lipworth BJ.
Thorax; 2002 Oct; 57(10):865-8. PubMed ID: 12324672
[Abstract] [Full Text] [Related]
20. Short-term growth and adrenal function in children with asthma treated with inhaled beclomethasone dipropionate hydrofluoroalkane-134a.
Wolthers OD.
Pediatr Allergy Immunol; 2006 Dec; 17(8):613-9. PubMed ID: 17121590
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
